WEST PHARMACEUTICAL SERVICES INC
WSTSEC CIK 105770Price charts ↗
Writing the earnings story…
Financials
Revenue+21.0% YoY
$844.9M
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
Net Income+54.6% YoY
$138.8M
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
EPS (diluted)+56.1% YoY
$1.92
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
Gross Margin+5.6% YoY
35.1%
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
| Quarter ending | Revenue | Net income | EPS |
|---|---|---|---|
| Mar 2026 | $844.9M | $138.8M | $1.92 |
| Sep 2025 | $804.6M | $140.0M | $1.92 |
| Jun 2025 | $766.5M | $131.8M | $1.82 |
| Mar 2025 | $698.0M | $89.8M | $1.23 |
| Sep 2024 | $746.9M | $136.0M | $1.85 |
| Jun 2024 | $702.1M | $111.3M | $1.51 |
| Mar 2024 | $695.4M | $115.3M | $1.55 |
| Sep 2023 | $747.4M | $161.3M | $2.14 |
Annual revenue
FY21FY22FY23FY24FY25
Source filings
Download the original reports from the SEC. A 10-Q is the quarterly update; a 10-K is the detailed annual report.
Quarterly report (10-Q)Filed 2026-04-23 · period ending 2026-03-31Open ↗Annual report (10-K)Filed 2026-02-17 · period ending 2025-12-31Open ↗Quarterly report (10-Q)Filed 2025-10-23 · period ending 2025-09-30Open ↗Quarterly report (10-Q)Filed 2025-07-24 · period ending 2025-06-30Open ↗Quarterly report (10-Q)Filed 2025-04-24 · period ending 2025-03-31Open ↗Annual report (10-K)Filed 2025-02-18 · period ending 2024-12-31Open ↗Quarterly report (10-Q)Filed 2024-10-24 · period ending 2024-09-30Open ↗Quarterly report (10-Q)Filed 2024-07-25 · period ending 2024-06-30Open ↗
Glossary
- Revenue
- Net income
- EPS
- Gross margin
- Net margin
- Fiscal year
Hover any underlined term for its definition.